Serum zinc levels and in vivo beta-amyloid deposition in the human brain

Abstract Background Despite the known associations between zinc levels and Alzheimer’s disease (AD) dementia and related cognitive impairment, the underlying neuropathological links remain poorly understood. We tested the hypothesis that serum zinc level is associated with cerebral beta-amyloid prot...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jee Wook Kim, Min Soo Byun, Dahyun Yi, Jun Ho Lee, Min Jung Kim, Gijung Jung, Jun-Young Lee, Koung Mi Kang, Chul-Ho Sohn, Yun-Sang Lee, Yu Kyeong Kim, Dong Young Lee, for the KBASE Research Group
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/40faa8b565bd416bbf8628dab1fcc9a1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:40faa8b565bd416bbf8628dab1fcc9a1
record_format dspace
spelling oai:doaj.org-article:40faa8b565bd416bbf8628dab1fcc9a12021-11-21T12:40:25ZSerum zinc levels and in vivo beta-amyloid deposition in the human brain10.1186/s13195-021-00931-31758-9193https://doaj.org/article/40faa8b565bd416bbf8628dab1fcc9a12021-11-01T00:00:00Zhttps://doi.org/10.1186/s13195-021-00931-3https://doaj.org/toc/1758-9193Abstract Background Despite the known associations between zinc levels and Alzheimer’s disease (AD) dementia and related cognitive impairment, the underlying neuropathological links remain poorly understood. We tested the hypothesis that serum zinc level is associated with cerebral beta-amyloid protein (Aβ) deposition. Additionally, we explored associations between serum zinc levels and other AD pathologies [i.e., tau deposition and AD-signature cerebral glucose metabolism (AD-CM)] and white matter hyperintensities (WMHs), which are measures of cerebrovascular injury. Methods A total of 241 cognitively normal older adults between 55 and 90 years of age were enrolled. All the participants underwent comprehensive clinical assessments, serum zinc level measurement, and multimodal brain imaging, including Pittsburgh compound B-positron emission tomography (PET), AV-1451 PET, fluorodeoxyglucose (FDG)-PET, and magnetic resonance imaging. Zinc levels were stratified into three categories: < 80 μg/dL (low), 80 to 90 μg/dL (medium), and > 90 μg/dL (high). Results A low serum zinc level was significantly associated with increased Aβ retention. In addition, apolipoprotein E ε4 allele (APOE4) status moderated the association: the relationship between low zinc level and Aβ retention was significant only in APOE4 carriers. Although a low zinc level appeared to reduce AD-CM, the relationship became insignificant on sensitivity analysis including only individuals with no nutritional deficiency. The serum zinc level was associated with neither tau deposition nor the WMH volume. Conclusions Our findings suggest that decreased serum zinc levels are associated with elevation of brain amyloid deposition. In terms of AD prevention, more attention needs to be paid to the role of zinc.Jee Wook KimMin Soo ByunDahyun YiJun Ho LeeMin Jung KimGijung JungJun-Young LeeKoung Mi KangChul-Ho SohnYun-Sang LeeYu Kyeong KimDong Young Leefor the KBASE Research GroupBMCarticleZincAβAlzheimer’s diseaseAPOE4Neurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENAlzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Zinc

Alzheimer’s disease
APOE4
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Zinc

Alzheimer’s disease
APOE4
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Jee Wook Kim
Min Soo Byun
Dahyun Yi
Jun Ho Lee
Min Jung Kim
Gijung Jung
Jun-Young Lee
Koung Mi Kang
Chul-Ho Sohn
Yun-Sang Lee
Yu Kyeong Kim
Dong Young Lee
for the KBASE Research Group
Serum zinc levels and in vivo beta-amyloid deposition in the human brain
description Abstract Background Despite the known associations between zinc levels and Alzheimer’s disease (AD) dementia and related cognitive impairment, the underlying neuropathological links remain poorly understood. We tested the hypothesis that serum zinc level is associated with cerebral beta-amyloid protein (Aβ) deposition. Additionally, we explored associations between serum zinc levels and other AD pathologies [i.e., tau deposition and AD-signature cerebral glucose metabolism (AD-CM)] and white matter hyperintensities (WMHs), which are measures of cerebrovascular injury. Methods A total of 241 cognitively normal older adults between 55 and 90 years of age were enrolled. All the participants underwent comprehensive clinical assessments, serum zinc level measurement, and multimodal brain imaging, including Pittsburgh compound B-positron emission tomography (PET), AV-1451 PET, fluorodeoxyglucose (FDG)-PET, and magnetic resonance imaging. Zinc levels were stratified into three categories: < 80 μg/dL (low), 80 to 90 μg/dL (medium), and > 90 μg/dL (high). Results A low serum zinc level was significantly associated with increased Aβ retention. In addition, apolipoprotein E ε4 allele (APOE4) status moderated the association: the relationship between low zinc level and Aβ retention was significant only in APOE4 carriers. Although a low zinc level appeared to reduce AD-CM, the relationship became insignificant on sensitivity analysis including only individuals with no nutritional deficiency. The serum zinc level was associated with neither tau deposition nor the WMH volume. Conclusions Our findings suggest that decreased serum zinc levels are associated with elevation of brain amyloid deposition. In terms of AD prevention, more attention needs to be paid to the role of zinc.
format article
author Jee Wook Kim
Min Soo Byun
Dahyun Yi
Jun Ho Lee
Min Jung Kim
Gijung Jung
Jun-Young Lee
Koung Mi Kang
Chul-Ho Sohn
Yun-Sang Lee
Yu Kyeong Kim
Dong Young Lee
for the KBASE Research Group
author_facet Jee Wook Kim
Min Soo Byun
Dahyun Yi
Jun Ho Lee
Min Jung Kim
Gijung Jung
Jun-Young Lee
Koung Mi Kang
Chul-Ho Sohn
Yun-Sang Lee
Yu Kyeong Kim
Dong Young Lee
for the KBASE Research Group
author_sort Jee Wook Kim
title Serum zinc levels and in vivo beta-amyloid deposition in the human brain
title_short Serum zinc levels and in vivo beta-amyloid deposition in the human brain
title_full Serum zinc levels and in vivo beta-amyloid deposition in the human brain
title_fullStr Serum zinc levels and in vivo beta-amyloid deposition in the human brain
title_full_unstemmed Serum zinc levels and in vivo beta-amyloid deposition in the human brain
title_sort serum zinc levels and in vivo beta-amyloid deposition in the human brain
publisher BMC
publishDate 2021
url https://doaj.org/article/40faa8b565bd416bbf8628dab1fcc9a1
work_keys_str_mv AT jeewookkim serumzinclevelsandinvivobetaamyloiddepositioninthehumanbrain
AT minsoobyun serumzinclevelsandinvivobetaamyloiddepositioninthehumanbrain
AT dahyunyi serumzinclevelsandinvivobetaamyloiddepositioninthehumanbrain
AT junholee serumzinclevelsandinvivobetaamyloiddepositioninthehumanbrain
AT minjungkim serumzinclevelsandinvivobetaamyloiddepositioninthehumanbrain
AT gijungjung serumzinclevelsandinvivobetaamyloiddepositioninthehumanbrain
AT junyounglee serumzinclevelsandinvivobetaamyloiddepositioninthehumanbrain
AT koungmikang serumzinclevelsandinvivobetaamyloiddepositioninthehumanbrain
AT chulhosohn serumzinclevelsandinvivobetaamyloiddepositioninthehumanbrain
AT yunsanglee serumzinclevelsandinvivobetaamyloiddepositioninthehumanbrain
AT yukyeongkim serumzinclevelsandinvivobetaamyloiddepositioninthehumanbrain
AT dongyounglee serumzinclevelsandinvivobetaamyloiddepositioninthehumanbrain
AT forthekbaseresearchgroup serumzinclevelsandinvivobetaamyloiddepositioninthehumanbrain
_version_ 1718418877810999296